PANCREATIC CANCER NON-RESECTABLE

Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear

Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 4

New hope for tough-to-treat pancreatic cancer

Disease control Not yet recruiting

This study is testing whether adding a new drug called tunlametinib to standard chemotherapy and another targeted drug works better for advanced pancreatic cancer. It's for adults who haven't had any prior cancer treatment. The goal is to see if this combination can shrink tumors…

Matched conditions: PANCREATIC CANCER NON-RESECTABLE

Phase: PHASE4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

PANCREATIC CANCER NON-RESECTABLE

Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear

New hope for tough-to-treat pancreatic cancer